# Altus Pharmaceuticals Assets

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/altus-pharmaceuticals-assets

- Industry: Pharmaceuticals
- Headquarters: Waltham, US
- Website: www.altus.com
- Total disclosed funding: $101M
- Latest round: Series C (May 25, 2004)
- Investors on record: 10

## About

Altus Pharmaceuticals is a company focused on specialized data center migration services and consulting, effectively meeting the complex needs of Fortune 500 and 1000 clients across a variety of sectors.Founded in Waltham, US, Altus Pharmaceuticals specializes in data center migration and consulting services. The company went public in January 2006, raising USD 105 mn through an IPO. It was acquired by Althea Technologies in May 2010. The company's founder has a history in technology ventures, although specific details about prior companies are not available.Altus Pharmaceuticals offers consulting and project-based services centered around data center migrations for large enterprises. Their offerings include data center relocation, consolidation, workload placement strategies, IT security assessments, and disaster recovery testing. Using the Altus Method, launched in 1996, the company ensures a structured framework for data center transformations, which extends globally to meet the needs of clients in North America and beyond.For the most recent fiscal year 2008, Altus Pharmaceuticals reported revenue of USD 2.16 mn and an EBITDA of USD -95.70 mn. The revenue is primarily generated through B2B consulting services and long-term partnerships, structured around project milestones to facilitate efficient data center transitions.In January 2006, Altus Pharmaceuticals conducted an IPO, selling 7 million shares at USD 15 each, raising a total of USD 105 mn. The funds acquired will support the company's initiatives in launching new products and expanding its reach into emerging markets. Specific markets targeted for expansion and potential product launches have not been detailed, but the company remains committed to enhancing its service offerings within the data management sector.

## Funding rounds

- Series C, May 25, 2004, $51M — US Venture Partners, Warburg Pincus, Presidio Partners, Phase4 Partners, BankInvest, Clariden Bank
- Series B, Dec 26, 2001, $15M — CDIB Capital Group, Presidio Partners, Hotung Investment Holdings, Palladian Capital Partners
- Series B, Oct 3, 2001, $35M — US Venture Partners, Nomura Asset Management, BankInvest, Clariden Bank

## Investors

- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B, Series C
- Nomura Asset Management (https://capitalatlas.ai/funds/nomura-asset-management) — Series B
- BankInvest (https://capitalatlas.ai/funds/bankinvest) — Series B, Series C
- Clariden Bank — Series B, Series C
- CDIB Capital Group (https://capitalatlas.ai/funds/cdib-capital-group) — Series B
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series B, Series C
- Hotung Investment Holdings (https://capitalatlas.ai/funds/hotung-investment-holdings) — Series B
- Palladian Capital Partners (https://capitalatlas.ai/funds/palladian-capital-partners) — Series B
- Warburg Pincus (https://capitalatlas.ai/funds/warburg-pincus) — Series C
- Phase4 Partners (https://capitalatlas.ai/funds/phase4-partners) — Series C